Compounds > berberine

berberine and thalifendine

berberine has been researched along with thalifendine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	8 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dutour, R; Poirier, D	1
Jiang, SH; Pan, JF; Ren, JY; Yu, C; Zeng, JF; Zhang, H; Zhu, DY	1
Akao, T; Hattori, M; Nakamura, N; Zuo, F	1
Jiang, JD; Kong, WJ; Li, Y; Li, YH; Li, ZR; Ren, G; Song, DQ; Wang, YM; Wang, YX; Yang, P; Yi, H	1
Chen, SN; Feng, R; Fu, J; He, CY; He, WY; Huang, M; Jiang, JD; Ma, C; Ma, JY; Shou, JW; Tan, XS; Wang, Y; Zhao, ZX	1
Liao, X; Liu, YM; Qing, LS; Shi, HL; Xiong, J; Xue, Y	1
Chen, WJ; Feng, R; Fu, J; He, CY; He, WY; Huang, M; Jiang, JD; Ma, C; Ma, JY; Shou, JW; Sun, YP; Tan, XS; Wang, Y	1
Chang, CY; Huang, CC; Lo, SN; Shen, CC; Tsai, KC; Ueng, YF; Wu, TS	1
Chang, YP; Huang, CC; Shen, CC; Tsai, KC; Ueng, YF	1
Chakrabarti, T; Chowdhury, SR; Jha, T; Kumar, A; Majumder, HK; Mukhopadhyay, S; Sarkar, T	1

Reviews

1 review(s) available for berberine and thalifendine

Article	Year
Inhibitors of cytochrome P450 (CYP) 1B1. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship	2017

Trials

1 trial(s) available for berberine and thalifendine

Article	Year
Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. Acta pharmacologica Sinica, 2002, Volume: 23, Issue:1 Topics: Adult; Antidiarrheals; Berberine; Humans; Magnetic Resonance Spectroscopy; Male; Spectrometry, Mass, Electrospray Ionization; Sulfates	2002

Other Studies

8 other study(ies) available for berberine and thalifendine

Article	Year
Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:12 Topics: Animals; Bacteria; Berberine; Bile; Chromatography, Liquid; Germ-Free Life; Intestinal Absorption; Intestine, Small; Liver; Male; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2006
Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. Journal of translational medicine, 2011, May-15, Volume: 9 Topics: AMP-Activated Protein Kinases; Animals; Berberine; Biotransformation; Cytochrome P-450 Enzyme System; Hep G2 Cells; Humans; Isoenzymes; Liver; Male; Metabolic Detoxication, Phase I; Rats; Rats, Wistar; Receptor, Insulin; Receptors, LDL	2011
Excretion of berberine and its metabolites in oral administration in rats. Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:11 Topics: Administration, Oral; Animals; Berberine; Bile; Chromatography, High Pressure Liquid; Feces; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry	2013
In vitro metabolic study of Rhizoma coptidis extract using liver microsomes immobilized on magnetic nanoparticles. Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:27 Topics: Animals; Berberine; Berberine Alkaloids; Bioreactors; Biotransformation; Chromatography, High Pressure Liquid; Coptis chinensis; Drugs, Chinese Herbal; Equipment Reuse; Kinetics; Magnetite Nanoparticles; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley	2013
Tissue distribution of berberine and its metabolites after oral administration in rats. PloS one, 2013, Volume: 8, Issue:10 Topics: Administration, Oral; Animals; Area Under Curve; Berberine; Chromatography, Liquid; Humans; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution	2013
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition. Drug metabolism and disposition: the biological fate of chemicals, 2015, Volume: 43, Issue:7 Topics: Berberine; Biotransformation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dealkylation; Escherichia coli; Humans; Isoenzymes; Kinetics; NADP; Oxidation-Reduction	2015
Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites. Drug metabolism and pharmacokinetics, 2015, Volume: 30, Issue:5 Topics: Berberine; Computer Simulation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Estradiol; Humans; Hydroxylation; Isoenzymes; Molecular Docking Simulation; Oxidation-Reduction; Recombinant Proteins	2015
A new bisbenzylisoquinoline alkaloid isolated from Thalictrum foliolosum, as a potent inhibitor of DNA topoisomerase IB of Leishmania donovani. Fitoterapia, 2016, Volume: 109 Topics: Alkaloids; Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Cells, Cultured; DNA Topoisomerases, Type I; Isoquinolines; Leishmania donovani; Macrophages, Peritoneal; Mice, Inbred BALB C; Molecular Structure; Thalictrum; Topoisomerase I Inhibitors	2016